Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 464 across all filing types
Latest filing 2020-02-11 Regulatory Filings
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2020-02-11 English
Press Release
Earnings Release Classification · 95% confidence The document is a media release announcing the financial results for the third quarter and nine months ended December 31, 2019 (Q3 & 9MFY20). It contains summarized financial performance data such as revenue, EBITDA, PAT, and EPS, along with management commentary. The document is relatively short (4871 characters) and formatted as a press release rather than a comprehensive financial report. It does not contain detailed financial statements or extensive analysis typical of an Interim/Quarterly Report (IR). Instead, it serves as an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). Q3 2020
2020-02-11 English
Press Release
Regulatory Filings
2020-02-11 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges reporting the outcome of a board meeting held on February 10, 2020. It states that the Board of Directors approved and took on record the unaudited financial results for the quarter and nine months ended December 31, 2019. It also mentions that a copy of the unaudited financial results along with a limited review report by statutory auditors is attached. The document itself does not contain the financial results or detailed financial data but rather announces the approval and availability of these results. The document length is only 1671 characters, which is quite short and consistent with an announcement rather than a full financial report. According to the "Menu vs Meal" rule, this is an announcement of the report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement of financial results and related documents without containing the full report.
2020-02-10 English
Updates
Regulatory Filings
2020-02-03 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended December 31, 2019. It is an intimation to stock exchanges and public about the meeting date and agenda, including the limited review report. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a regulatory announcement about the meeting and the forthcoming financial results, not the financial report itself. The document is short (2135 characters) and serves as a notification rather than a report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2020-02-01 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.